Nanopath: Streamlined Framework for Pathology Model Development
Nanopath is an open-source framework designed to streamline the training and evaluation of small-scale pathology foundation models. It allows researchers to leverage a single H100 GPU to train models...
Key Facts
- Accelerate model training processes using Nanopath to reduce time-to-insight in pathology research.
- Utilize fixed data and compute budgets to ensure equitable comparisons across research submissions.
- Enhance transparency in research outcomes by adhering to consistent evaluation protocols.
- Leverage quick evaluation times to iterate on promising training methodologies efficiently.
- Foster innovation in pathology by enabling rapid testing of research ideas on smaller datasets.
Summary
Paper: Nanopath: Fast, Fair, Open Experimentation for Pathology Foundation Models
Authors: Paul S. Scotti, Hassan Muhammad, Ryan Kim, Nima Ashjaee, Ratna Sagari Grandhi, Saman Rahbar, Raymond Biju, Anish Dulal, Chao Feng, Connor Lane, Benjamin Warner, Tanishq Mathew Abraham
Executive Summary
Nanopath is an open-source framework designed to streamline the training and evaluation of small-scale pathology foundation models. It allows researchers to leverage a single H100 GPU to train models in just over an hour on up to one million pathology tile presentations from the TCGA (The Cancer Genome Atlas) database. The evaluation process for these models takes approximately 25 minutes and covers a variety of tasks at both tile and slide levels.
This framework is significant because it enables quick testing of research ideas at a smaller scale, making it easier to identify promising training methodologies that can later be applied to larger datasets. To ensure fairness in comparisons among different research submissions, the framework imposes fixed data and compute budgets while maintaining a consistent evaluation protocol. This structure promotes transparency and repeatability in research outcomes.
Since its public launch in June 2026, Nanopath has facilitated 1,269 experiments from 20 contributors, reflecting its acceptance within the research community. The platform includes a public experiment ledger called Labless, where users can access previous experiments, clone the codebase, download data, and modify existing models. This openness allows for collaboration and innovation among students, researchers, and AI agents exploring pathology foundation modeling.
The research demonstrates that Nanopath’s rapid evaluation process effectively tracks established benchmarks such as THUNDER, HEST, and PathoBench (CPTAC). Notably, some models with only 22 million parameters have even surpassed the performance of larger models with over 1.1 billion parameters in certain downstream tasks. This finding suggests that smaller, well-optimized models could be competitive alternatives to their larger counterparts.
Additionally, the team has made further optimizations to Nanopath's evaluation suite, enhancing its reliability as a quick proxy for external benchmarking. These improvements increase the framework's utility as a testbed for various users in the field of pathology research, supporting fair and directly comparable experimental results.
Overall, Nanopath represents a significant advancement in the ability to develop and assess pathology models efficiently. Its open-source nature and rapid evaluation capabilities could foster innovation in medical research, potentially leading to improved diagnostic tools and treatments in the future.
Academic Abstract
We introduce nanopath, an open-source framework and benchmark for rapidly training and evaluating small-scale pathology foundation models. Using a single H100 GPU, a typical nanopath model trains in a little over an hour on up to one million TCGA pathology tile presentations and evaluates within 25 minutes on a broad suite of tile-level and slide-level tasks. Nanopath enables rapid exploration of research ideas at small scale, so promising training recipes can subsequently be tested with more data and compute. To enable fair comparisons between ideas, we constrain submissions to fixed data and compute budgets while keeping the downstream evaluation protocol fixed. Anyone may clone the codebase, automatically download the data, reproduce or modify existing models, and submit a run to Labless, our public experiment ledger where researchers and AI agents can search through prior attempts. Since its public release in June 2026, nanopath has received 1,269 experiments from 20 contributors. Here, we detail its design and assess how well its rapid evaluation tracks standardized THUNDER, HEST, and PathoBench (CPTAC) benchmarks across six nanopath and 14 reference foundation models. Nanopath's fast evaluation suite strongly tracked these standardized benchmarks, and a few 22M parameter nanopath models even outperformed giant 1.1B parameter models on a subset of downstream tasks. We subsequently discuss how we have since optimized nanopath's evaluation suite to be an even more faithful, quick proxy for external benchmarking. Nanopath provides an accessible testbed for students, researchers, and AI agents to explore pathology foundation modeling through fair, transparent, and directly comparable experiments.
Frequently Asked Questions
What business problems does Nanopath address?
Nanopath addresses the problem of slow and inefficient training and evaluation processes for pathology models by streamlining these tasks, allowing researchers to quickly test and identify promising methodologies in a structured and fair manner.
Which industries benefit most from the implementation of Nanopath?
The healthcare and biotechnology industries, particularly those focused on pathology and cancer research, may benefit most from Nanopath due to its ability to facilitate rapid experimentation and development of pathology models.
What are the practical implementation considerations for using Nanopath in a business setting?
Practical implementation considerations include ensuring access to the necessary computational resources, such as an H100 GPU, and establishing protocols for maintaining the fixed data and compute budgets required for fair evaluations.
What resources or expertise are needed to effectively utilize Nanopath?
Organizations would need expertise in pathology research, machine learning, and familiarity with open-source frameworks, as well as access to appropriate computational resources to leverage the capabilities of Nanopath effectively.
What competitive advantages does Nanopath offer to organizations in the pathology field?
Nanopath offers competitive advantages through faster experimentation cycles, enhanced transparency, and repeatability in research outcomes, which could lead to quicker advancements in pathology model development compared to traditional methods.